Viewing nowCombinationTrulinam Tablets 2.5/1000 mg (Linagliptin, Metformin Hydrochloride)
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.

MFDS item code 201902368 · Approved 2019.04.17 · Insurance code 641906990
Improvement of glycemic control in patients with type 2 diabetes
This medication aids blood sugar control in patients with type 2 diabetes by combining linagliptin and metformin. It is given as an adjunct to dietary and exercise therapy to help effectively manage blood sugar levels. This helps maintain stable blood sugar and improve diabetes management.
The dose of this medicine should be determined according to each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: linagliptin 2.5 mg and metformin 1000 mg twice daily. This medicine is administered twice daily with meals. To reduce gastrointestinal adverse reactions associated with metformin use, the dose should be increased gradually. 1. Patients not currently treated with metformin: For patients who have not previously received pharmacological treatment for diabetes and whose blood glucose is inadequately controlled with monotherapy, the initial dose is 1 tablet of this medicine 2.5/500 mg twice daily. The dose may be increased to 1 tablet of this medicine 2.5/1000 mg twice daily. 2. Patients whose blood glucose is inadequately controlled with metformin monotherapy: The initial dose of this medicine should provide linagliptin 2.5 mg twice daily (total daily dose 5 mg) and the patient's current dose of metformin (e.g., a patient taking metformin 1000 mg twice daily should take linagliptin 2.5 mg/metformin 1000 mg twice daily with meals). 3. Switching from combination therapy with linagliptin and metformin: Patients switching from combination therapy with linagliptin and metformin to this medicine should start at their current doses of linagliptin and metformin. 4. Patients whose blood glucose is inadequately controlled with combination therapy of metformin and a sulfonylurea: The initial dose of this medicine should be considered to provide linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's current metformin dose. When this medicine is administered in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 3. Patients Requiring Caution). 5. Patients whose blood glucose is inadequately controlled with combination therapy of insulin and metformin: The initial dose of this medicine should be considered to provide linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's current metformin dose. When this medicine is administered in combination with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 3. Patients Requiring Caution). No studies have been conducted to evaluate the safety and efficacy of switching to this medicine in patients previously treated with another oral antihyperglycemic agent. Any change in the treatment regimen for type 2 diabetes may alter blood glucose control; therefore, caution should be exercised and appropriate monitoring should be performed. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate (eGFR) 45≤~<60 mL/min/1.73 m2), who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Because the starting dose of metformin is 500mg or 850mg once daily, treatment should not be initiated with this medicine. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine must be discontinued immediately. Patients with hepatic impairment This medicine should not be administered to patients with hepatic impairment because it contains metformin (see Precautions for Use, 2. Patients in Whom This Medicine Must Not Be Used).
This medication helps in blood sugar control. However, one of the ingredients, metformin hydrochloride, can cause a serious side effect known as lactic acidosis, so caution is necessary. This medication should not be administered to certain patients. For example, those who are allergic to any of the components, patients with type 1 diabetes, severe renal impairment, acute heart disease, liver dysfunction, acute alcohol intoxication, or women who are pregnant or breastfeeding should not take this medication. Additionally, there is a risk of hypoglycemia; therefore, when used in conjunction with sulfonylureas or insulin, dose adjustments may be required. Elderly patients with reduced renal function or those expecting changes in renal function should undergo regular kidney function checks and discontinue this medication if severe renal impairment occurs. Patients with unstable cardiac function, severe illnesses, or those undergoing surgery should use this medication with caution, and if undergoing tests using iodinated contrast agents, should discontinue its use before and after the test. This medication may cause gastrointestinal disturbances as side effects, such as diarrhea, abdominal pain, vomiting, and decreased appetite. Rarely, it may lead to acute pancreatitis or skin blistering diseases, and if such symptoms arise, immediate consultation with a doctor is necessary. It is preferable for pregnant or breastfeeding women to avoid this medication, especially if planning for pregnancy, in which case consulting with a doctor for appropriate treatment options is advisable. Use in children under 10 years of age is not recommended, as the safety and efficacy of this medication in that age group have not been established. Elderly individuals are at risk of renal function decline; therefore, dose adjustments and regular kidney function tests are required. Alcohol consumption should be avoided while taking this medication, and if taken with other medications that may affect renal function, consultation with a doctor is necessary. In case of overdose, serious side effects like lactic acidosis may occur, requiring immediate medical attention; dialysis may also be needed. This medication should be stored in a sealed container to protect it from moisture, and kept out of reach of children. It is best not to transfer it to another container. Finally, if sudden joint pain or blistering of the skin occurs during treatment with this medication, inform a doctor immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius. Proper storage will ensure the longevity of the medication's effectiveness and safety.
Bright pink, double convex oval-shaped film-coated tablets
30 tablets/bottle, 60 tablets/bottle, 100 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Anguk Pharm Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.